Coya Therapeutics (COYA) Return on Equity [ROE] (2023 - 2026)
Coya Therapeutics (COYA) posted Return on Equity [ROE] of -48.37% for Q2 2026, up 22.75 percentage points from -71.12% a year earlier but down 1.05 percentage points from the prior quarter.
Powered by 
Analysis
Coya Therapeutics (COYA) Return on Equity [ROE] (2023 - 2026) Analysis & Trends
For FY2025, Coya Therapeutics' Return on Equity [ROE] came in at -51.39%, down 11.82 percentage points from FY2024.
- In prior years, Coya Therapeutics' Return on Equity [ROE] was -39.57% in FY2024 (+19.07 pp) and -58.64% in FY2023.
- Quarterly Return on Equity [ROE] has run from a low of -283.85% in Q1 2023 to a high of -28.65% in Q2 2024 over five years.
- On a year-over-year basis, Return on Equity [ROE] increased in three of the last eight quarters, with an average year-over-year change of -4.53 percentage points.
- The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was Q1 2024, with a gain of 254.29 percentage points; the weakest was Q2 2025, with a drop of 42.46 percentage points.
- According to Business Quant data, Return on Equity [ROE] for the three prior quarters was -47.32% (Q1 2026), -62.20% (Q4 2025) and -71.64% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | Coya Therapeutics | 74.13 Mn | -102.42 Mn | - | -78.52% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -78.52% |
| Jun 30, 2026 | -46.98% |
| Mar 31, 2026 | -45.92% |
| Dec 31, 2025 | -60.37% |
| Sep 30, 2025 | -70.50% |
| Jun 30, 2025 | -71.12% |
| Mar 31, 2025 | -51.35% |
| Dec 31, 2024 | -46.03% |
| Sep 30, 2024 | -31.45% |
| Jun 30, 2024 | -28.65% |
| Mar 31, 2024 | -29.56% |
| Dec 31, 2023 | -34.57% |
| Sep 30, 2023 | -100.46% |
| Jun 30, 2023 | -73.60% |
| Mar 31, 2023 | -283.85% |
API Access
Coya Therapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=COYA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "COYA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=COYA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();